Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
LifeStance Health Group, Inc. reported the first quarter ended March 31, 2024 results: revenue $300.4 million, net income ($21.1 million). Guidance raised.
- Period
- the first quarter ended March 31, 2024
- Revenue
- $300.4 million
- Net income
- ($21.1 million)
- Guidance
- raised
- Result
- reported results
Exact text from the filing
LifeStance Reports First Quarter 2024 Results SCOTTSDALE, Ariz. – May 9, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted) Q1 2024 Highlights and FY 2024 Outlook • Revenue of $300.4 million increased 19% compared to revenue of $252.6 million • Clinician base increased 15% to 6,866 clinicians, a sequential net increase of 221 in the first quarter • First quarter visit volumes increased 15% to 1.9 million • Net loss of $21.1 million, primarily driven by stock-based compensation, compared to net loss of $34.2 million
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Danish Qureshi departed as President and Chief Operating Officer at LifeStance Health Group, Inc..
- Action
- notified his decision to depart
- Role
- President and Chief Operating Officer
Exact text from the filing
On May 6, 2024, Danish Qureshi, the President and Chief Operating Officer of LifeStance Health Group, notified the Company of his decision to depart the Company, effective June 30, 2024.
View on SEC.gov